eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | barrett esophagus |
| Comorbidity | C0001418|adenocarcinomas |
| Sentences | 5 |
| PubMedID- 21345220 | Lgr5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without barrett's esophagus. |
| PubMedID- 21866548 | The localisation of urokinase-type plasminogen activator receptor (upar) was determined in 66 patients; 60 with adenocarcinomas and six cases with barrett's oesophagus. |
| PubMedID- 20946664 | There were n = 41 esophageal adenocarcinomas (eac) with associated barrett's esophagus (be), n = 19 eac without be and n = 10 esophageal squamous-cell carcinomas of the esophagus (which were intended to serve as positive control for mmp-1 expression), and n = 18 barrett's biopsies without intraepithelial neoplasia or invasive carcinoma which were derived from patients with gastroesophageal reflux disease (gerd). |
| PubMedID- 24570883 | Advanced esophageal adenocarcinomas arising from barrett esophagus (be) are tumors with an increasing incidence and poor prognosis. |
| PubMedID- 21698030 | The majority of lower esophageal adenocarcinomas appear in patients with barrett's esophagus (be), a premalignant condition in which the normal squamous epithelium is replaced by metaplastic columnar epithelium. |
Page: 1